Flora Growth Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	74.78	76.07	33.4	8.98	0.11
Revenue Growth (YoY)	54.13%	127.75%	271.95%	8371.70%	-
Cost of Revenue	58.54	58.33	20.15	6.56	0.04
Gross Profit	16.25	17.74	13.25	2.43	0.07
Selling, General & Admin	6.59	6.77	12.25	5.11	1.83
Research & Development	0.09	0.06	0.39	0.13	0.08
Other Operating Expenses	60.03	61.26	47.83	16.19	12.45
Operating Expenses	66.72	68.09	60.47	21.43	14.36
Operating Income	-50.47	-50.35	-47.22	-19	-14.28
Interest Expense / Income	0.09	0.09	-0.03	0.03	0.03
Other Expense / Income	6.97	7.53	6.84	2.42	0.02
Pretax Income	-57.53	-57.98	-54.03	-21.46	-14.33
Income Tax	-1.42	-1.63	-1.41	-0.1	0
Net Income	-56.11	-56.35	-52.63	-21.36	-14.33
Shares Outstanding (Basic)	9	7	4	2	1
Shares Outstanding (Diluted)	9	7	4	2	1
Shares Change	34.28%	91.96%	74.36%	47.00%	-
EPS (Basic)	-7.60	-7.75	-13.68	-9.60	-9.40
EPS (Diluted)	-7.62	-7.75	-13.68	-9.60	-9.40
Free Cash Flow	-5.56	-8.56	-17.23	-24.92	-8.66
Free Cash Flow Per Share	-0.62	-1.16	-4.50	-11.34	-5.79
Gross Margin	21.72%	23.32%	39.67%	27.00%	66.98%
Operating Margin	-67.49%	-66.19%	-141.38%	-211.61%	-13475.47%
Profit Margin	-75.03%	-74.07%	-157.57%	-237.87%	-13522.64%
Free Cash Flow Margin	-7.44%	-11.25%	-51.58%	-277.53%	-8165.09%
EBITDA	-55.83	-55.4	-51.43	-20.93	-14.19
EBITDA Margin	-74.65%	-72.83%	-153.99%	-233.03%	-13387.74%
Depreciation & Amortization	1.62	2.48	2.63	0.5	0.11
EBIT	-57.44	-57.88	-54.06	-21.43	-14.3
EBIT Margin	-76.81%	-76.09%	-161.86%	-238.61%	-13494.34%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).